Stem cells inhaled into lungs: a new hope for COPD?
NCT ID NCT06986070
First seen Feb 17, 2026 · Last updated May 23, 2026 · Updated 14 times
Summary
This early-stage study tests whether a new stem cell treatment, called SORT-COPD, is safe for people with mild to moderate chronic obstructive pulmonary disease (COPD). The treatment involves delivering small mobile stem cells directly into the lungs. The study will enroll 18 adults aged 39 to 69 and will check for side effects at three different doses.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE LUNG DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Doherty Clinical Trials Limited
NOT_YET_RECRUITINGMelbourne, Victoria, 3002, Australia
-
Veritus Research
RECRUITINGBayswater, Victoria, 3153, Australia
Conditions
Explore the condition pages connected to this study.